Role of δ-tocotrienol and resveratrol supplementation in the regulation of micro RNAs in patients with metabolic syndrome: a randomized controlled trial.

[1]  Aamir Ijaz,et al.  Hepato-Protective Effects of Delta-Tocotrienol and Alpha-Tocopherol in Patients with Non-Alcoholic Fatty Liver Disease: Regulation of Circulating MicroRNA Expression , 2022, International journal of molecular sciences.

[2]  M. Teimouri,et al.  Anti-inflammatory effects of resveratrol in patients with cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials. , 2022, Complementary therapies in medicine.

[3]  D. Khan,et al.  Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial. , 2022, Complementary therapies in medicine.

[4]  S. Ima-Nirwana,et al.  Effects of tocotrienols supplementation on markers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials , 2021, PloS one.

[5]  D. Khan,et al.  Effects of delta‐tocotrienol supplementation on Glycemic Control, oxidative stress, inflammatory biomarkers and miRNA expression in type 2 diabetes mellitus: A randomized control trial , 2021, Phytotherapy research : PTR.

[6]  K. Magalhães,et al.  The Impact of Adipose Tissue–Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer , 2020, Frontiers in Endocrinology.

[7]  A. Śliwińska,et al.  The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress , 2020, International journal of molecular sciences.

[8]  Aamir Ijaz,et al.  Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial. , 2020, Complementary therapies in medicine.

[9]  M. Górska,et al.  Circulating miRNAs as a Predictive Biomarker of the Progression from Prediabetes to Diabetes: Outcomes of a 5-Year Prospective Observational Study , 2020, Journal of clinical medicine.

[10]  K. Marycz,et al.  Non-Coding RNAs as Potential Novel Biomarkers for Early Diagnosis of Hepatic Insulin Resistance , 2020, International journal of molecular sciences.

[11]  J. Markworth,et al.  Circulatory miRNA biomarkers of metabolic syndrome , 2019, Acta Diabetologica.

[12]  Adel Derghal,et al.  MicroRNAs in Obesity and Related Metabolic Disorders , 2019, Cells.

[13]  S. Ye,et al.  δ-Tocotrienol feeding modulates gene expression of EIF2, mTOR, protein ubiquitination through multiple-signaling pathways in chronic hepatitis C patients , 2018, Lipids in Health and Disease.

[14]  G. Gupta,et al.  Role of microRNAs (miRNAs) in the pathophysiology of diabetes mellitus. , 2018, Panminerva medica.

[15]  M. Cherkaoui-Malki,et al.  Resveratrol-Induced Changes in MicroRNA Expression in Primary Human Fibroblasts Harboring Carnitine-Palmitoyl Transferase-2 Gene Mutation, Leading to Fatty Acid Oxidation Deficiency , 2017, Molecules.

[16]  Ravi Kasiappan,et al.  Role of MicroRNA Regulation in Obesity-Associated Breast Cancer: Nutritional Perspectives. , 2017, Advances in nutrition.

[17]  M. Portillo,et al.  Potential miRNA involvement in the anti-adipogenic effect of resveratrol and its metabolites , 2017, PloS one.

[18]  M. Portillo,et al.  Are miRNA-103, miRNA-107 and miRNA-122 Involved in the Prevention of Liver Steatosis Induced by Resveratrol? , 2017, Nutrients.

[19]  Hsin-Ching Sung,et al.  Resveratrol attenuates ICAM-1 expression and monocyte adhesiveness to TNF-α-treated endothelial cells: evidence for an anti-inflammatory cascade mediated by the miR-221/222/AMPK/p38/NF-κB pathway , 2017, Scientific Reports.

[20]  Kai Wang,et al.  A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus , 2017, International journal of molecular sciences.

[21]  A. Śliwińska,et al.  MicroRNAs and metabolic disorders – where are we heading? , 2017, Archives of medical science : AMS.

[22]  H. Mo,et al.  Peroxisome proliferator-activated receptor γ down-regulation mediates the inhibitory effect of d-δ-tocotrienol on the differentiation of murine 3T3-F442A preadipocytes. , 2016, Nutrition research.

[23]  A. Novials,et al.  Circulating microRNAs as biomarkers for metabolic disease. , 2016, Best practice & research. Clinical endocrinology & metabolism.

[24]  S. Vienberg,et al.  MicroRNAs in metabolism , 2016, Acta physiologica.

[25]  J. Deiuliis.  MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics , 2015, International Journal of Obesity.

[26]  M. Veysey,et al.  The role of vitamins and minerals in modulating the expression of microRNA , 2014, Nutrition Research Reviews.

[27]  M. Garcia-Conesa,et al.  Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence , 2013, Current pharmaceutical design.

[28]  Alberto Dávalos,et al.  One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. , 2013, Pharmacological research.

[29]  Emmette R. Hutchison,et al.  miR-130 Suppresses Adipogenesis by Inhibiting Peroxisome Proliferator-Activated Receptor γ Expression , 2010, Molecular and Cellular Biology.

[30]  A. Basit,et al.  Prevalence of metabolic syndrome in urban Pakistan (Karachi): comparison of newly proposed International Diabetes Federation and modified Adult Treatment Panel III criteria. , 2009, Metabolic syndrome and related disorders.

[31]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[32]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[33]  H. Nguyen.  Effect of nutrition intervention on the prevalence of metabolic syndrome at Kon Tum General Hospital, Vietnam , 2022, Journal of Complementary Medicine Research.

[34]  A. L. Ferreira,et al.  The role of oxidative stress on the pathophysiology of metabolic syndrome. , 2017, Revista da Associacao Medica Brasileira.